ATE227290T1 - Verbesserung bei der herstellung von n-(3-(3- cyanopyrazolo(1,5-a)pyrimidin-7-yl)phenyl)-n- ethyl-acetamide - Google Patents
Verbesserung bei der herstellung von n-(3-(3- cyanopyrazolo(1,5-a)pyrimidin-7-yl)phenyl)-n- ethyl-acetamideInfo
- Publication number
- ATE227290T1 ATE227290T1 AT96308630T AT96308630T ATE227290T1 AT E227290 T1 ATE227290 T1 AT E227290T1 AT 96308630 T AT96308630 T AT 96308630T AT 96308630 T AT96308630 T AT 96308630T AT E227290 T1 ATE227290 T1 AT E227290T1
- Authority
- AT
- Austria
- Prior art keywords
- cyanopyrazolo
- acetamide
- pyrimidine
- phenyl
- ethyl
- Prior art date
Links
- HUNXMJYCHXQEGX-UHFFFAOYSA-N zaleplon Chemical compound CCN(C(C)=O)C1=CC=CC(C=2N3N=CC(=C3N=CC=2)C#N)=C1 HUNXMJYCHXQEGX-UHFFFAOYSA-N 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/10—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US785995P | 1995-12-01 | 1995-12-01 |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE227290T1 true ATE227290T1 (de) | 2002-11-15 |
Family
ID=21728482
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT96308630T ATE227290T1 (de) | 1995-12-01 | 1996-11-28 | Verbesserung bei der herstellung von n-(3-(3- cyanopyrazolo(1,5-a)pyrimidin-7-yl)phenyl)-n- ethyl-acetamide |
Country Status (25)
Country | Link |
---|---|
US (1) | US5714607A (de) |
EP (1) | EP0776898B1 (de) |
JP (1) | JP4112032B2 (de) |
KR (1) | KR100439282B1 (de) |
CN (1) | CN1057525C (de) |
AR (1) | AR004822A1 (de) |
AT (1) | ATE227290T1 (de) |
AU (1) | AU718310B2 (de) |
BR (1) | BR9605760A (de) |
CA (1) | CA2191647C (de) |
CY (1) | CY2440B1 (de) |
CZ (1) | CZ292253B6 (de) |
DE (1) | DE69624657T2 (de) |
DK (1) | DK0776898T3 (de) |
ES (1) | ES2184844T3 (de) |
HU (1) | HU226398B1 (de) |
IL (1) | IL119710A (de) |
MX (1) | MX9605974A (de) |
NO (1) | NO307181B1 (de) |
NZ (1) | NZ299848A (de) |
PT (1) | PT776898E (de) |
RU (1) | RU2178415C2 (de) |
SK (1) | SK281807B6 (de) |
TW (1) | TW382629B (de) |
ZA (1) | ZA9610008B (de) |
Families Citing this family (27)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6399621B1 (en) | 1999-08-10 | 2002-06-04 | American Cyanamid Company | N-methyl-N-(3-{3-[2-thienylcarbonyl]-pyrazol-[1, 5-α]-pyrimidin-7-yl}phenyl)acetamide and compositions and methods related thereto |
US6485746B1 (en) | 2000-08-25 | 2002-11-26 | Neurocrine Biosciences, Inc. | Controlled-release sedative-hypnotic compositions and methods related thereto |
US20030091632A1 (en) * | 1999-08-26 | 2003-05-15 | Neurocrine Biosciences, Inc. | Controlled-release sedative-hypnotic compositions and methods related thereto |
US6384221B1 (en) * | 1999-09-02 | 2002-05-07 | Neurocrine Biosciences, Inc. | Polymorphs of N-methyl-N-(3-{3-[2-thienylcarbonyl]-pyrazol-[1,5-α]-pyrimidin-7-yl}phenyl)acetamide and compositions and methods related thereto |
SG125971A1 (en) * | 2000-08-03 | 2006-10-30 | Wyeth Corp | Variable water hydrates of zaleplon and method forthe preparation thereof |
EP1526136A1 (de) * | 2000-08-03 | 2005-04-27 | Wyeth | Polymorphe Formen von Zaleplon und Verfahren zu ihrer Herstellung |
AR029780A1 (es) | 2000-12-13 | 2003-07-16 | Gador Sa | Procedimiento mejorado para la obtencion de n-[3(3-ciano-pirazolo[1,5-a]pirimidin-7-il)fenil]-n-etil-acetamida |
EP1406871A4 (de) * | 2001-06-12 | 2005-01-26 | Biogal Gyogyszergyar | VERFAHREN ZUR HERSTELLUNG VON N ç3 (3 CYANOPYRAZOLOç1,5 A!PYRIMIDIN 7 YL)PHENYL!-N-ETHYLACETAMID (ZALEPLON) |
US20050032818A1 (en) * | 2001-06-12 | 2005-02-10 | Entire Interest | N-[3-(3-cyanopyrazolo[1,5-a]pyrimidin-5-yl)phenyl]-N-ethylacetamide and crystalline forms of zaleplon |
US6852858B2 (en) * | 2001-08-01 | 2005-02-08 | Biogal Gyogyszergyar Rt. | Process for purifying N-[3-(3-cyanopyrazolo[1,5-a]pyrimidin-7-yl)phenyl]-N-ethylacetamide (zaleplon) and crystalline forms of zaleplon accessible with the process |
DE50307812D1 (de) * | 2002-02-14 | 2007-09-13 | Cilag Ag | Verfahren zur herstellung von n-ethyl-n-(3-(3-cyanopyrazolo-(1,5-a)-pyrimidin-7-yl)phenyl)-acetamid |
EP1490068A1 (de) * | 2002-02-15 | 2004-12-29 | Biogal Gyogyszergyar Rt. | Pulverzusammensetzung mit zaleplon mit definierter teilchengrössenverteilung und daraus hergestellte pharmazeutische produkte |
PL207322B1 (pl) * | 2002-05-14 | 2010-11-30 | Adamed Społka Z Ograniczoną Odpowiedzialnością | Sposób wytwarzania zaleplonu |
KR101248123B1 (ko) * | 2003-09-04 | 2013-03-27 | 씨아이피엘에이 엘티디. | 잘레플론의 합성 |
ES2515092T3 (es) | 2003-12-11 | 2014-10-29 | Sunovion Pharmaceuticals Inc. | Combinación de un sedante y un modulador neurotransmisor y métodos de mejorar la calidad del sueño y de tratar la depresión |
DE602004025747D1 (de) * | 2004-01-14 | 2010-04-08 | Mallinckrodt Inc | Zweiphasiges verfahren zur synthese ausgewählter pyrazolopyrimidine |
HUP0400325A3 (en) * | 2004-02-02 | 2005-11-28 | Richter Gedeon Vegyeszet | Pure n-[3-(-cyanopyrazolo[1,5-a]pyrimidin-7-yl)phenyl]-n-ethyl-acetamide, process for its preparation and intermediates |
WO2005079851A2 (en) | 2004-02-18 | 2005-09-01 | Sepracor, Inc. | Dopamine-agonist combination therapy with sedatives for improving sleep quality |
WO2006070244A2 (en) * | 2004-11-22 | 2006-07-06 | Bakulesh Mafatlal Khamar | A process for the preparation of zaleplon |
US7649007B2 (en) * | 2006-08-15 | 2010-01-19 | Wyeth Llc | Oxazolidine derivatives as PR modulators |
WO2008021309A1 (en) * | 2006-08-15 | 2008-02-21 | Wyeth | Imidazolidin-2-one derivatives useful as pr modulators |
WO2008021337A1 (en) | 2006-08-15 | 2008-02-21 | Wyeth | Oxazinan-2-one derivatives useful as pr modulators |
TW200815428A (en) * | 2006-08-15 | 2008-04-01 | Wyeth Corp | Oxazolidone derivatives as PR modulators |
WO2008068600A2 (en) * | 2006-12-06 | 2008-06-12 | Orchid Chemicals & Pharmaceuticals Limited | An improved process for the preparation of zaleplo |
CZ2008468A3 (cs) | 2008-07-31 | 2009-11-18 | Farmak, A. S. | Zpusob prípravy N-(1-benzo[b]thien-2-ylethyl)-N-hydroxymocoviny |
CN102816163A (zh) * | 2012-08-20 | 2012-12-12 | 四川禾邦阳光制药股份有限公司 | 扎来普隆的新晶型及制备方法 |
CN112694336B (zh) * | 2020-12-29 | 2021-11-16 | 哈尔滨工业大学 | 一种高纯α相氮化硅纤维毡的制备方法 |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4281000A (en) * | 1979-07-09 | 1981-07-28 | American Cyanamid Company | Substituted pyrazolo (1,5-a)pyrimidines and their use as anxiolytic agents |
US4521422A (en) * | 1983-06-23 | 1985-06-04 | American Cyanamid Company | Aryl and heteroaryl[7-(aryl and heteroaryl)pyrazolo[1,5-a]pyrimidin-3-yl]methanones |
US4626538A (en) * | 1983-06-23 | 1986-12-02 | American Cyanamid Company | [7-(3-disubstituted amino)phenyl]pyrazolo[1,5-a]pyrimidines |
NZ208554A (en) * | 1983-06-23 | 1987-06-30 | American Cyanamid Co | (aryl and heteroaryl)-(7-(aryl and heteroaryl)-pyrazolo (1,5-a) pyrimidin-3-yl)-methanone derivatives and pharmaceutical compositions |
JPS62270584A (ja) * | 1986-04-28 | 1987-11-24 | Yoshitomi Pharmaceut Ind Ltd | 4,7−ジヒドロピラゾロ〔1,5−a〕ピリミジン誘導体 |
GB9321162D0 (en) * | 1993-10-13 | 1993-12-01 | Boots Co Plc | Therapeutic agents |
-
1996
- 1996-11-25 US US08/758,132 patent/US5714607A/en not_active Expired - Lifetime
- 1996-11-28 ZA ZA9610008A patent/ZA9610008B/xx unknown
- 1996-11-28 DK DK96308630T patent/DK0776898T3/da active
- 1996-11-28 PT PT96308630T patent/PT776898E/pt unknown
- 1996-11-28 EP EP96308630A patent/EP0776898B1/de not_active Expired - Lifetime
- 1996-11-28 IL IL11971096A patent/IL119710A/xx not_active IP Right Cessation
- 1996-11-28 DE DE69624657T patent/DE69624657T2/de not_active Expired - Lifetime
- 1996-11-28 AT AT96308630T patent/ATE227290T1/de active
- 1996-11-28 ES ES96308630T patent/ES2184844T3/es not_active Expired - Lifetime
- 1996-11-28 NO NO965084A patent/NO307181B1/no not_active IP Right Cessation
- 1996-11-28 HU HU9603275A patent/HU226398B1/hu unknown
- 1996-11-29 JP JP31909596A patent/JP4112032B2/ja not_active Expired - Fee Related
- 1996-11-29 AR ARP960105438A patent/AR004822A1/es active IP Right Grant
- 1996-11-29 MX MX9605974A patent/MX9605974A/es unknown
- 1996-11-29 CZ CZ19963505A patent/CZ292253B6/cs not_active IP Right Cessation
- 1996-11-29 RU RU96122857/04A patent/RU2178415C2/ru not_active IP Right Cessation
- 1996-11-29 SK SK1536-96A patent/SK281807B6/sk not_active IP Right Cessation
- 1996-11-29 CA CA002191647A patent/CA2191647C/en not_active Expired - Fee Related
- 1996-11-29 NZ NZ299848A patent/NZ299848A/en not_active IP Right Cessation
- 1996-11-29 KR KR1019960059652A patent/KR100439282B1/ko not_active IP Right Cessation
- 1996-11-29 AU AU74091/96A patent/AU718310B2/en not_active Ceased
- 1996-11-29 TW TW085114751A patent/TW382629B/zh not_active IP Right Cessation
- 1996-11-29 BR BR9605760A patent/BR9605760A/pt not_active Application Discontinuation
- 1996-11-30 CN CN96118985A patent/CN1057525C/zh not_active Expired - Fee Related
-
2004
- 2004-05-06 CY CY0400035A patent/CY2440B1/xx unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE227290T1 (de) | Verbesserung bei der herstellung von n-(3-(3- cyanopyrazolo(1,5-a)pyrimidin-7-yl)phenyl)-n- ethyl-acetamide | |
DE921133T1 (de) | Herstellung von Gummiartikeln | |
DE69905652T2 (de) | Direkte Herstellung von Pyrrolo-(3,4-c)pyrrolpigmenten | |
DE69624413D1 (de) | Verbesserungen bei der Herstellung von Halbleitervorrichtungen | |
FI864423A (fi) | N-substituerade-n-/3-(1,2,4-triazolo /4,3-b-/pyridazin-6-yl)fenyl/alkanamider, karbamater och urreas | |
DE59806703D1 (de) | Herstellung von Formteilen | |
DE69515140D1 (de) | Planarisierung in der Herstellung von Anordnungen | |
DE69508074D1 (de) | Herstellung von porösen körpern | |
DE69624959T2 (de) | Herstellung von Pentafluorphenylverbindungen | |
DE69804513T2 (de) | Herstellung von zeolith-l | |
DE69525518T2 (de) | Herstellung von Raketenkammern | |
DE69618264T2 (de) | Verbesserungen bei der Herstellung von Kristallsubstraten | |
DE69507949T2 (de) | Herstellung von keramischen formkörpern | |
DE69502001T2 (de) | Herstellung von uranoxid | |
DE69516467D1 (de) | Feste Lösungen von Pyrrolo-(3,4-c)-pyrrolen mit Chinacridonchinonen | |
DE69502395T2 (de) | Herstellung von triarylboran | |
DE69521513D1 (de) | Herstellung von keramischen artikeln | |
DE69702961D1 (de) | Herstellung von 1,1-difluorethan | |
DE59510186D1 (de) | Cyaniminogruppen enthaltende Pyrrolo(3,4-c)pyrrole | |
DE69811864D1 (de) | Herstellung von bandförmigen werkstücken | |
DE69101849D1 (de) | Herstellung von Amiden. | |
DE69611546D1 (de) | Herstellung von 2,6-dimethylnaphthalin | |
DE69112758T2 (de) | Herstellung von Aminonitrilen. | |
DE69809562D1 (de) | Herstellung von verbrückte hafnocene | |
DE69905139D1 (de) | Verbesserungen bei der herstellung von pulvern |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
UEP | Publication of translation of european patent specification |
Ref document number: 0776898 Country of ref document: EP |
|
EEFA | Change of the company name | ||
EEIH | Change in the person of patent owner |